# Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma

> **NCT00740597** · PHASE2 · TERMINATED · sponsor: **City of Hope Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** western blotting
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00740597
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** No patients were enrolled on the study
- **Last updated:** 2014-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740597, "Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00740597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*